Tumour vanishes in all 12 rectal cancer patients in rare medical trial result
Posted on 08-June-2022
Rectal cancer occurs when cancer cells develop in the rectum's tissues; colorectal cancer occurs in the colon or rectum.
Colon and rectal cancers are the third most common cancers diagnosed in the United States and the second most lethal. Rectal cancer differs from colon cancer in terms of environmental associations and genetic risk factors. The incidence of new cases and mortality from rectal cancer has been steadily declining in recent years, despite a recent increase in younger adults (less than 50 years).
Treatment for rectal cancer is primarily determined by cancer's stage (extent), but other factors may also be considered.
Rectal cancers that have not spread to other parts of the body are usually treated surgically. Before or after surgery, radiation, and chemotherapy (chemo) may be conducted. As per recent research news regarding the treatment of rectal cancer, there is a possibility that it can be disappeared by using Immunotherapy.
As per the latest news, after six months of treatment as the first patient in an immunotherapy clinical trial at MSK, Dr. Cercek informed Sascha, then 38, that her latest tests revealed no evidence of cancer. (Source)
Immunotherapy is a type of cancer treatment in which the immune system is used to attack cancer cells in the same way that it would attack bacteria or viruses. The MSK clinical trial was testing whether immunotherapy alone could beat rectal cancer that had not spread to other tissues in a subset of patients with a specific genetic mutation.
